Effect of calcium channel blockers and angiotensin i converting enzyme inhibitors on the kidney
Wiecek, A.
Polski Tygodnik Lekarski 47(49-50): 1115-1117
1992
ISSN/ISBN: 0032-3756 PMID: 1305740 Document Number: 394393
Document emailed within 1 workday
Related Documents
Sinaiko, A.R. 1994: Clinical pharmacology of converting enzyme inhibitors, calcium channel blockers and diuretics Journal of Human Hypertension 8(5): 389-394Rudolf, W.; Froer, K.L.; Hall, D. 1982: New drug preparations used for treating congestive heart failure: converting enzyme inhibitors, nitroprusside, nitrates and calcium channel blockers Terapevticheskii Arkhiv 54(11): 110-112
Surabenjawong, U.; Thunpiphat, N.; Chatsiricharoenkul, S.; Monsomboon, A. 2013: Prevalence of hyperkalemia in adult patients taking spironolactone and angiotensin converting enzyme inhibitors or angiotensin receptor blockers Journal of the Medical Association of Thailand 96(8): 905-910
Wang, L.; Cai, S.-r.; Zhang, C.-h.; He, Y.-l.; Zhan, W.-h.; Wu, H.; Peng, J.-j. 2008: Effects of angiotensin converting enzyme inhibitors and angiotensin Ii receptor blockers on angiogenesis of gastric cancer in a nude mouse model Zhonghua Wei Chang Wai Ke Za Zhi 11(6): 565-568
Wang, L.; Cai, S.-r.; Zhang, C.-h.; He, Y.-l.; Zhan, W.-h.; Wu, H.; Peng, J.-j. 2008: Effects of angiotensin-converting enzyme inhibitors and angiotensin Ii type 1 receptor blockers on lymphangiogenesis of gastric cancer in a nude mouse model Chinese Medical Journal 121(21): 2167-2171
Vijan, S.G. 2009: Angiotensin-converting enzyme inhibitors (ACEIs), not angiotensin receptor blockers (ARBs), are preferred and effective mode of therapy in high cardiovascular risk patients Journal of the Indian Medical Association 107(3): 178-182
Fayssoil, A. 2010: Angiotensin-converting enzyme inhibitors and beta-blockers in cardiac asymptomatic patients with Duchenne muscular dystrophy Indian Heart Journal 62(3): 273
Ohtahara, A.; Hisatome, I.; Yamamoto, Y.; Furuse, M.; Sonoyama, K.; Furuse, Y.; Hamada, T.; Katoh, M.; Watanabe, M.; Kinugawa, T.; Ogino, K.; Igawa, O.; Shimomura, T.; Murakami, F.; Yamamoto, T.; Shigemasa, C. 2001: The release of the substrate for xanthine oxidase in hypertensive patients was suppressed by angiotensin converting enzyme inhibitors and alpha1-blockers Journal of Hypertension 19(3 Pt 2): 575-582
Kutyrina, I.M.; Tareeva, I.E.; Gerasimenko, O.I.; Rogov, V.A.; Miroshnichenko, N.G. 1995: The use of angiotensin-converting enzyme inhibitors in chronic diffuse kidney diseases Terapevticheskii Arkhiv 67(5): 20-23
Wang, L-chun.; Ma, H.; He, J-gui.; Liao, X-xue.; Chen, W-fang.; Leng, X-yu.; Ma, L.; Mai, W-yi.; Tao, J.; Zeng, W-tao.; Liu, J.; Dong, Y-gang.; Tang, A-li.; Feng, C. 2005: Effect of angiotensin converting enzyme inhibitor on the calcium transients and calcium handling proteins in ventricular myocytes from rats with heart failure Chinese Medical Journal 118(9): 731-737
Oda, M.; Ino, Y.; Suzuki, K.; Sato, T.; Iwamoto, S.; Iwaki, M. 1989: Angiotensin converting enzyme inhibitory activity of MK-0521 in vivo and antihypertensive effect of its single oral administration on blood pressure and effect on the renin-angiotensin system in 2-kidney Goldblatt hypertensive dogs Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 93(4): 225-234
Bönner, G. 1988: Do kinins have significance for the antihypertensive effect of angiotensin-converting enzyme inhibitors? Zeitschrift für Kardiologie 77(Suppl 3): 23-27
Zhang, X.-h.; Ma, X.-j.; Luo, J.; Shao, J.-h.; Geng, Q.-x.; Zhu, X.-l.; Tang, Y.-s.; Xu, F.-y. 2004: Effect of different angiotensin converting enzyme inhibitors on coronary collateral circulation Zhonghua Yi Xue Za Zhi 84(7): 592-595
Ramalho, F.S.; Ramalho, L.N.Z.; Castro-e-Silva Júnior, O.; Zucoloto, Sérgio.; Corrêa, F.M.A. 2002: Effect of angiotensin-converting enzyme inhibitors on liver regeneration in rats Hepato-Gastroenterology 49(47): 1347-1351
Bauwens, L.J.; Copper, M.P.; Schmidt, J.T. 1995: Life-threatening angioedema as a side effect of angiotensin-converting-enzyme (ACE) inhibitors Nederlands Tijdschrift Voor Geneeskunde 139(13): 674-677
Ol'binskaia, L.I.; Golokolenova, G.M.; Kuznetsov, V.A. 1994: The kallikrein-kinin system: its significance in circulatory failure and the effect of angiotensin I-converting enzyme inhibitors Terapevticheskii Arkhiv 66(9): 88-92
Wojewódzka-Zelezniakowicz, M.; Chabielska, E.; Mogielnicki, A.; Kramkowski, K.; Karp, A.; Opadczuk, A.; Domaniewski, T.; Malinowska-Zaprzałka, M.; Buczko, W. 2006: Antithrombotic effect of tissue and plasma type angiotensin converting enzyme inhibitors in experimental thrombosis in rats Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society 57(2): 231-245
Ganten, D.; Mullins, J.; Lindpaintner, K. 1989: The tissue renin-angiotensin system: a target for angiotensin-converting enzyme inhibitors Journal of Human Hypertension 3(Suppl 1): 63-70
De Paz, S.; Martín, A.B.; Iglesias, A.; Domínguez, A.R. 1999: Angioedema-urticaria caused by angiotensin-converting enzyme inhibitors and angiotensin Ii receptor antagonists Medicina Clinica 113(19): 759
Jover, B.; Mimran, A. 1994: Angiotensin II receptor antagonists versus angiotensin converting enzyme inhibitors: effects on renal function Journal of Hypertension. Supplement: Official Journal of the International Society of Hypertension 12(9): S3-S9